Miransertib
CAS: 1313881-70-7
Ref. 3D-NCC88170
| 1mg | Ausgelaufen | ||
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
Miransertib
Beschreibung:
Miransertib is an inhibitor of the enzyme protein kinase, which plays a key role in the development and progression of many diseases. Miransertib has been shown to inhibit tumor growth and induce neuronal death in animal models. It also inhibits the activity of kinases that are not associated with cancer, but have been implicated in other disease states such as metabolic syndrome. Miransertib has synergistic effects when combined with nonsteroidal anti-inflammatory drugs (NSAIDs) in inhibiting inflammation-driven colon cancer. This drug may be useful for treating patients who have a genetic mutation that causes their tumors to grow more quickly than normal.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
432.52 g/mol
Formel:
C27H24N6
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
